Overview
Piebaldism (also known as partial albinism or piebald trait) is a rare congenital disorder of melanocyte development characterized by the absence of melanocytes in affected areas of the skin and hair, resulting in distinctive patches of white skin (leukoderma) and white hair (poliosis). It is caused by mutations in the KIT proto-oncogene (most commonly) or the SLUG (SNAI2) gene, which are critical for the migration and survival of melanoblasts from the neural crest during embryonic development. The condition is present from birth and remains stable throughout life. The hallmark feature of piebaldism is a white forelock (a triangular or diamond-shaped depigmented patch of hair on the frontal scalp), which is present in approximately 80-90% of affected individuals. Depigmented patches of skin are typically found on the forehead, anterior trunk (chest and abdomen), and extremities, often with a characteristic midline distribution. These white patches may contain islands of normal or hyperpigmented skin within them. The borders of the depigmented areas frequently show hyperpigmented macules. Importantly, piebaldism does not affect other organ systems — hearing, vision, and neurological function are normal, which distinguishes it from Waardenburg syndrome and other neurocristopathies that also feature pigmentary abnormalities. Piebaldism is a benign condition, and no specific medical treatment is required. However, the depigmented skin lacks melanocytes and is therefore more susceptible to sunburn and potentially to sun-related skin damage, so sun protection is recommended. Cosmetic concerns can be addressed with camouflage cosmetics, and some patients have undergone autologous melanocyte transplantation or skin grafting with variable success. Genetic counseling is appropriate for affected families given the autosomal dominant inheritance pattern with high penetrance but variable expressivity.
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Piebaldism.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Piebaldism at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Piebaldism.
Community
No community posts yet. Be the first to share your experience with Piebaldism.
Start the conversation →Latest news about Piebaldism
No recent news articles for Piebaldism.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Piebaldism
What is Piebaldism?
Piebaldism (also known as partial albinism or piebald trait) is a rare congenital disorder of melanocyte development characterized by the absence of melanocytes in affected areas of the skin and hair, resulting in distinctive patches of white skin (leukoderma) and white hair (poliosis). It is caused by mutations in the KIT proto-oncogene (most commonly) or the SLUG (SNAI2) gene, which are critical for the migration and survival of melanoblasts from the neural crest during embryonic development. The condition is present from birth and remains stable throughout life. The hallmark feature of pie
How is Piebaldism inherited?
Piebaldism follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Piebaldism typically begin?
Typical onset of Piebaldism is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Piebaldism?
10 specialists and care centers treating Piebaldism are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.